75 related articles for article (PubMed ID: 30859224)
1. Kinase PIM1 promotes prostate cancer cell growth via c-Myc-RPS7-driven ribosomal stress.
Zhang C; Qie Y; Yang T; Wang L; Du E; Liu Y; Xu Y; Qiao B; Zhang Z
Carcinogenesis; 2019 Mar; 40(1):202. PubMed ID: 30859224
[No Abstract] [Full Text] [Related]
2. Kinase PIM1 promotes prostate cancer cell growth via c-Myc-RPS7-driven ribosomal stress.
Zhang C; Qie Y; Yang T; Wang L; Du E; Liu Y; Xu Y; Qiao B; Zhang Z
Carcinogenesis; 2019 Mar; 40(1):52-60. PubMed ID: 30247545
[TBL] [Abstract][Full Text] [Related]
3. PIM kinase inhibitor AZD1208 for treatment of MYC-driven prostate cancer.
Kirschner AN; Wang J; van der Meer R; Anderson PD; Franco-Coronel OE; Kushner MH; Everett JH; Hameed O; Keeton EK; Ahdesmaki M; Grosskurth SE; Huszar D; Abdulkadir SA
J Natl Cancer Inst; 2015 Feb; 107(2):. PubMed ID: 25505253
[TBL] [Abstract][Full Text] [Related]
4. RPS7 promotes cell migration through targeting epithelial-mesenchymal transition in prostate cancer.
Wen Y; An Z; Qiao B; Zhang C; Zhang Z
Urol Oncol; 2019 May; 37(5):297.e1-297.e7. PubMed ID: 30737160
[TBL] [Abstract][Full Text] [Related]
5. PIM1 kinase as a target in prostate cancer: roles in tumorigenesis, castration resistance, and docetaxel resistance.
Holder SL; Abdulkadir SA
Curr Cancer Drug Targets; 2014; 14(2):105-14. PubMed ID: 24274399
[TBL] [Abstract][Full Text] [Related]
6. PIM1 destabilization activates a p53-dependent response to ribosomal stress in cancer cells.
Sagar V; Caldarola S; Aria V; Monteleone V; Fuoco C; Gargioli C; Cannata S; Loreni F
Oncotarget; 2016 Apr; 7(17):23837-49. PubMed ID: 26993775
[TBL] [Abstract][Full Text] [Related]
7. Regulation of prostate stromal fibroblasts by the PIM1 protein kinase.
Zemskova MY; Song JH; Cen B; Cerda-Infante J; Montecinos VP; Kraft AS
Cell Signal; 2015 Jan; 27(1):135-46. PubMed ID: 25451079
[TBL] [Abstract][Full Text] [Related]
8. PIM1-dependent phosphorylation of histone H3 at serine 10 is required for MYC-dependent transcriptional activation and oncogenic transformation.
Zippo A; De Robertis A; Serafini R; Oliviero S
Nat Cell Biol; 2007 Aug; 9(8):932-44. PubMed ID: 17643117
[TBL] [Abstract][Full Text] [Related]
9. Pim1 regulates androgen-dependent survival signaling in prostate cancer cells.
van der Poel HG; Zevenhoven J; Bergman AM
Urol Int; 2010; 84(2):212-20. PubMed ID: 20215828
[TBL] [Abstract][Full Text] [Related]
10. PIM1 is responsible for IL-6-induced breast cancer cell EMT and stemness via c-myc activation.
Gao X; Liu X; Lu Y; Wang Y; Cao W; Liu X; Hu H; Wang H
Breast Cancer; 2019 Sep; 26(5):663-671. PubMed ID: 30989585
[TBL] [Abstract][Full Text] [Related]
11. PIM1 overexpression in T-cell lymphomas protects tumor cells from apoptosis and confers doxorubicin resistance by upregulating c-myc expression.
Xiang X; Yuan D; Liu Y; Li J; Wen Q; Kong P; Gao L; Zhang C; Gao L; Peng X; Zhang X
Acta Biochim Biophys Sin (Shanghai); 2018 Aug; 50(8):800-806. PubMed ID: 30020405
[TBL] [Abstract][Full Text] [Related]
12. A functional SUMO-motif in the active site of PIM1 promotes its degradation via RNF4, and stimulates protein kinase activity.
Iyer RS; Chatham L; Sleigh R; Meek DW
Sci Rep; 2017 Jun; 7(1):3598. PubMed ID: 28620180
[TBL] [Abstract][Full Text] [Related]
13. Synergism of cytoplasmic kinases in IL6-induced ligand-independent activation of androgen receptor in prostate cancer cells.
Kim O; Jiang T; Xie Y; Guo Z; Chen H; Qiu Y
Oncogene; 2004 Mar; 23(10):1838-44. PubMed ID: 14981536
[TBL] [Abstract][Full Text] [Related]
14. RPS7 inhibits colorectal cancer growth via decreasing HIF-1α-mediated glycolysis.
Zhang W; Tong D; Liu F; Li D; Li J; Cheng X; Wang Z
Oncotarget; 2016 Feb; 7(5):5800-14. PubMed ID: 26735579
[TBL] [Abstract][Full Text] [Related]
15. The Natural Compound Myricetin Effectively Represses the Malignant Progression of Prostate Cancer by Inhibiting PIM1 and Disrupting the PIM1/CXCR4 Interaction.
Ye C; Zhang C; Huang H; Yang B; Xiao G; Kong D; Tian Q; Song Q; Song Y; Tan H; Wang Y; Zhou T; Zi X; Sun Y
Cell Physiol Biochem; 2018; 48(3):1230-1244. PubMed ID: 30045021
[TBL] [Abstract][Full Text] [Related]
16. Identification of quinones as novel PIM1 kinase inhibitors.
Schroeder RL; Goyal N; Bratton M; Townley I; Pham NA; Tram P; Stone T; Geathers J; Nguyen K; Sridhar J
Bioorg Med Chem Lett; 2016 Jul; 26(13):3187-3191. PubMed ID: 27173800
[TBL] [Abstract][Full Text] [Related]
17. Pim1 and Myc reversibly transform murine precursor B lymphocytes but not mature B lymphocytes.
Bouquet C; Melchers F
Eur J Immunol; 2012 Feb; 42(2):522-32. PubMed ID: 22101984
[TBL] [Abstract][Full Text] [Related]
18. HistoneH3 demethylase JMJD2A promotes growth of liver cancer cells through up-regulating miR372.
An J; Xu J; Li J; Jia S; Li X; Lu Y; Yang Y; Lin Z; Xin X; Wu M; Zheng Q; Pu H; Gui X; Li T; Lu D
Oncotarget; 2017 Jul; 8(30):49093-49109. PubMed ID: 28467776
[TBL] [Abstract][Full Text] [Related]
19. The Dual Inhibition of RNA Pol I Transcription and PIM Kinase as a New Therapeutic Approach to Treat Advanced Prostate Cancer.
Rebello RJ; Kusnadi E; Cameron DP; Pearson HB; Lesmana A; Devlin JR; Drygin D; Clark AK; Porter L; Pedersen J; Sandhu S; Risbridger GP; Pearson RB; Hannan RD; Furic L
Clin Cancer Res; 2016 Nov; 22(22):5539-5552. PubMed ID: 27486174
[TBL] [Abstract][Full Text] [Related]
20. PIM1 kinase promotes cell proliferation, metastasis and tumor growth of lung adenocarcinoma by potentiating the c-MET signaling pathway.
Cao L; Wang F; Li S; Wang X; Huang D; Jiang R
Cancer Lett; 2019 Mar; 444():116-126. PubMed ID: 30583073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
